News & Updates

Inside Innovation

The latest news and advances from the world's most exciting life science cluster.

Improving care for CLL patients

Adaptive Biotechnologies received FDA clearance for the clonoSEQ® Assay, used to assess the minimal residual disease in a chronic lymphocytic leukemia patient’s blood. Previously, the

Read More »